ABIONYX Pharma Yönetim

Yönetim kriter kontrolleri 4/4

ABIONYX Pharma's CEO is Cyrille Tupin, appointed in Sep 2019, has a tenure of 5.17 years. total yearly compensation is €278.85K, comprised of 79.1% salary and 20.9% bonuses, including company stock and options. directly owns 4.59% of the company’s shares, worth €2.00M. The average tenure of the management team and the board of directors is 5.2 years and 8.5 years respectively.

Anahtar bilgiler

Cyrille Tupin

İcra Kurulu Başkanı

€278.8k

Toplam tazminat

CEO maaş yüzdesi79.1%
CEO görev süresi5.2yrs
CEO sahipliği4.6%
Yönetim ortalama görev süresi5.2yrs
Yönetim Kurulu ortalama görev süresi8.5yrs

Son yönetim güncellemeleri

Recent updates

Does ABIONYX Pharma (EPA:ABNX) Have A Healthy Balance Sheet?

Jun 26
Does ABIONYX Pharma (EPA:ABNX) Have A Healthy Balance Sheet?

Is ABIONYX Pharma (EPA:ABNX) Using Too Much Debt?

Oct 12
Is ABIONYX Pharma (EPA:ABNX) Using Too Much Debt?

Will ABIONYX Pharma (EPA:ABNX) Spend Its Cash Wisely?

Jan 27
Will ABIONYX Pharma (EPA:ABNX) Spend Its Cash Wisely?

CEO Tazminat Analizi

Cyrille Tupin'un ücretlendirmesi ABIONYX Pharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-€3m

Mar 31 2024n/an/a

-€3m

Dec 31 2023€279k€221k

-€4m

Sep 30 2023n/an/a

-€4m

Jun 30 2023n/an/a

-€4m

Mar 31 2023n/an/a

-€4m

Dec 31 2022€289k€210k

-€4m

Sep 30 2022n/an/a

-€5m

Jun 30 2022n/an/a

-€6m

Mar 31 2022n/an/a

-€6m

Dec 31 2021€649k€200k

-€6m

Sep 30 2021n/an/a

-€5m

Jun 30 2021n/an/a

-€4m

Mar 31 2021n/an/a

-€3m

Dec 31 2020€711k€200k

-€2m

Sep 30 2020n/an/a

-€2m

Jun 30 2020n/an/a

-€2m

Mar 31 2020n/an/a

-€59k

Dec 31 2019n/an/a

€2m

Sep 30 2019n/an/a

€925k

Jun 30 2019n/an/a

€1k

Mar 31 2019n/an/a

-€3m

Dec 31 2018€5m€175k

-€6m

Tazminat ve Piyasa: Cyrille's total compensation ($USD304.29K) is about average for companies of similar size in the French market ($USD326.18K).

Tazminat ve Kazançlar: Cyrille's compensation has been consistent with company performance over the past year.


CEO

Cyrille Tupin (48 yo)

5.2yrs

Görev süresi

€278,848

Tazminat

Sir Cyrille Tupin, CPA is Chief Executive Officer, General Manager and Director at ABIONYX Pharma SA since September 6, 2019. Mr. Tupin served as the Chief Financial and Administrative Officer at ABIONYX...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Cyrille Tupin
CEO, GM & Director5.2yrs€278.85k4.59%
€ 2.0m
Christian Chavy
Independent Director5.8yrs€29.25kVeri yok
Emmanuel Fougeroux
Administrative & Financial Directorno dataVeri yokVeri yok
Constance Peyrottes
Vice President of Clinicalno dataVeri yokVeri yok
Robert Andrew Scott
Chief Medical Officer and Head of R&Dless than a yearVeri yokVeri yok
Laurent Guerci
Chief Digital & Innovation Officerno dataVeri yokVeri yok

5.2yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim: ABNX's management team is seasoned and experienced (5.2 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Cyrille Tupin
CEO, GM & Director5.2yrs€278.85k4.59%
€ 2.0m
Christian Chavy
Independent Director9.8yrs€29.25kVeri yok
Olivier Martinez
Censor9.8yrsVeri yokVeri yok
Michael Davidson
Chairman of Scientific Advisory Boardno data€23.00kVeri yok
Karen Noël
Independent Director7.4yrs€29.25kVeri yok
Laura Coruzzi
Independent Director9.5yrs€18.75kVeri yok
Emmanuel Huynh
Chairman of the Board5.3yrs€22.05k12.54%
€ 5.5m

8.5yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ABNX's board of directors are considered experienced (8.5 years average tenure).